- Details
- Rashid Sayyid and Zach Klaassen delve into the significance of racial disparities in prostate cancer treatment through a subgroup analysis of the ARASENS trial, which notably focused on Black patients. This pivotal trial assessed the efficacy of adding darolutamide to ADT and docetaxel in metastatic hormone-sensitive prostate cancer, revealing that Black patients, despite historically higher morta...
|
- Details
- Matthew Cooperberg introduces the inaugural patient-oriented journal club for patients diagnosed with prostate cancer. This patient journal club aims to highlight prostate cancer research, selected trials, and pivot to open discussion between expert clinicians and patients. The 15-year update from the ProtecT trial, led by Professors Freddie Hamdy and Jenny Donovan is the selected trial for this s...
|
- Details
- In this Prostate Cancer Patient Journal Club discussion, Matthew Cooperberg and Jenny Donovan address quality-of-life outcomes from the ProtecT trial's surveillance group. Jenny notes that those who did not progress avoided radical treatment impacts, with no significant quality of life difference compared to radically treated patients. Group discussion includes side effects and global variability...
|
- Details
- Rashid Sayyid and Zach Klaassen discuss the Society for Immunotherapy of Cancer and the International Bladder Cancer Group's recommendations for clinical trials in bladder cancer. They focus on low and intermediate-risk non-muscle invasive bladder cancer, emphasizing the need for well-designed trials to advance treatment. The panel, comprising 25 multidisciplinary experts, aims to guide late-phase...
|
- Details
- Rashid Sayyid and Zach Klaassen discuss recommendations from the Society for Immunotherapy of Cancer and the International Bladder Cancer Group on clinical trial designs for bladder cancer. They focus on locally advanced and metastatic urothelial carcinoma, emphasizing the need for new treatments and rational trial designs. The panel, comprising 25 multidisciplinary experts, aims to guide late-pha...
|
- Details
- Rashid Sayyid and Zach Klaassen discuss the Society for Immunotherapy of Cancer and the International Bladder Cancer Group's recommendations for clinical trial design in high-risk non-muscle-invasive bladder cancer. The consensus statement, led by Dr. Ashish Kamat and published in the Journal of Clinical Oncology, aims to guide investigators in late-phase clinical trial design. The panel, comprisi...
|
- Details
- Rashid Sayyid and Zach Klaassen discuss recommendations from the Society for Immunotherapy of Cancer and the International Bladder Cancer Group for muscle-invasive bladder cancer (MIBC) clinical trial design. Published in the Journal of Clinical Oncology with Dr. Ashish Kamat as lead author, these guidelines aim to advance treatment for urothelial carcinoma. The 25-member panel, including a patien...
|
- Details
- Rashid Sayyid and Zach Klaassen discuss the amended AUA guidelines for advanced prostate cancer, focusing on bone health and future directions. They emphasize the importance of bone health, particularly for men with advanced prostate cancer who are at increased risk of bone complications due to age, ADT treatment, and bone metastases. The guidelines recommend assessing the risk of fragility fractu...
|
- Details
- Rashid Sayyid and Zach Klaassen discuss the amended AUA guidelines on advanced prostate cancer, focusing on biochemically recurrent prostate cancer without metastasis after local treatment. The guidelines emphasize informing patients about the risk of developing metastatic disease and recommend serial PSA measurements and clinical evaluations. High-risk patients, identified by pathologic grade or...
|
- Details
- Rashid Sayyid and Zach Klaassen discuss the 2023 AUA guidelines for managing lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). They clarify evidence grades: Grade A for high-certainty studies and Grade C for flawed or limited ones. BPH, a proliferation of prostatic tissue, is testosterone-dependent. The duo explains the dynamic and static components contributing to LUT...
|
